Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acipimox in Metabolic Syndrome
NCT00759291Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2006
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acipimox in metabolic syndrome, sponsored by Brigham and Women's Hospital. Started Apr 2006; status: completed.
02
Drugs
acipimox
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00759291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00759291.